Shilpi Ratra, OD
Optometry · Rohnert Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ratra’s office at (707) 206-3000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C14482 · Cancelled
Licence status: Cancelled · since 1952 · Loyola University of Chicago Stritch School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$8,280 in 2024
Medicaid paid $8,280 for 358 billed services this clinician did in 2024, up to 35 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 58 | $4,235 |
| DETERMINATION REFRACTIVE STATE | 257 | $2,428 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 28 | $942 |
| New patient visit (30+ min) | 15 | $675 |
| 2024 | 358 | 4 | 35 | $8,280 |
| 2023 | 421 | 3 | 30 | $541 |
| 2022 | 322 | 4 | 36 | $242 |
| 2021 | 603 | 3 | 44 | $477 |
| 2020 | 212 | 3 | 35 | $241 |
| 2019 | 30 | 1 | 16 | $16 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 148 | $429 |
| DETERMINATION REFRACTIVE STATE | 255 | $111 |
| Frames, purchases | 18 | $0 |
2022
| Short return visit (20+ min) | 84 | $191 |
| DETERMINATION REFRACTIVE STATE | 184 | $51 |
| New patient visit (30+ min) | 41 | $0 |
| Frames, purchases | 13 | $0 |
2021
| Short return visit (20+ min) | 205 | $335 |
| DETERMINATION REFRACTIVE STATE | 347 | $79 |
| New patient visit (30+ min) | 51 | $63 |
2020
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 26 | $100 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 33 | $77 |
| DETERMINATION REFRACTIVE STATE | 153 | $64 |
2019
| DETERMINATION REFRACTIVE STATE | 30 | $16 |
Drugs they prescribed that Part D paid
$4,656
Pharmacies billed $4,656 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 105) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
77 generic and 28 brand-name prescriptions · $4,656 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluorometholone | 17 | $1,638 | $96 |
| Cyclosporine | 13 | $1,276 | $98 |
| Prednisolone Acetate | 11 | $553 | $50 |
| Neomycin-Polymyxin-Dexameth | 17 | $223 | $13 |
| Latanoprost | 11 | $180 | $16 |
See all 6 drugs
| Fluorometholone | 17 | $1,638 | $96 |
| Cyclosporine | 13 | $1,276 | $98 |
| Prednisolone Acetate | 11 | $553 | $50 |
| Neomycin-Polymyxin-Dexameth | 17 | $223 | $13 |
| Latanoprost | 11 | $180 | $16 |
| Erythromycin | 13 | $176 | $14 |
Year by year
| 2024 | 105 | 51 | 0% (0) | 27% | $4,656 |
| 2023 | 155 | 71 | 0% (0) | 27% | $7,671 |
| 2022 | 136 | 57 | 0% (0) | 22% | $11,894 |
| 2021 | 153 | 75 | 0% (0) | 23% | $17,869 |
| 2020 | 88 | 45 | 0% (0) | 17% | $8,379 |
| 2019 | 81 | 48 | 0% (0) | 28% | $8,030 |
| 2014 | 37 | 16 | 0% (0) | 95% | $8,281 |
| 2013 | 32 | 12 | 0% (0) | 97% | $8,135 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Cyclosporine | 14 | $1,722 | $123 |
| Olopatadine | 67 | $1,492 | $22 |
| Prednisolone Acetate | 11 | $562 | $51 |
| Erythromycin | 12 | $179 | $15 |
2022: 4 drugs
| Cequa | 17 | $8,523 | $501 |
| Olopatadine | 63 | $1,314 | $21 |
| Latanoprost | 19 | $332 | $17 |
| Neomycin-Polymyxin-Dexameth | 11 | $133 | $12 |
2021: 4 drugs
| Cequa | 15 | $10,104 | $674 |
| Olopatadine | 72 | $1,072 | $15 |
| Latanoprost | 15 | $293 | $20 |
| Neomycin-Polymyxin-Dexameth | 13 | $164 | $13 |
2020: 3 drugs
| Olopatadine | 25 | $386 | $15 |
| Latanoprost | 16 | $318 | $20 |
| Neomycin-Polymyxin-Dexameth | 12 | $184 | $15 |
2019: 2 drugs
| Neomycin-Polymyxin-Dexameth | 25 | $440 | $18 |
| Latanoprost | 13 | $229 | $18 |
2013: 1 drug
| Pataday | 16 | $2,350 | $147 |
Professional record
- NPI
- 1407121239
- Licence
- CA 14482California C14482: Cancelled
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 34485 Raindeer Ct, Fremont, CA, 94555
- NPI first listed
- 2012-03-12
- NPI last updated
- 2022-02-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.